Daniel Gesua Sive Salvadori - 30 Jan 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Daniel Gesua Sive Salvadori by Jessica H. Paik, Attorney-in-Fact
Issuer symbol: ABT
Transactions as of: 30 Jan 2025
Net transactions value: -$2,141,767
Form type: 4
Filing time: 31 Jan 2025, 19:08:40 UTC
Previous filing: 04 Mar 2024
Next filing: 27 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$912,806	+23,771	+19%	$38.40	149,468	30 Jan 2025	Direct
transaction	ABT	Common shares without par value	Sale	$3,054,574	-23,771	-16%	$128.50	125,697	30 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-23,771	-100%	$0.000000	0	30 Jan 2025	Common Shares	23,771	$38.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.